Prediction of intestinal permeability.

This review focuses on computational methods for the prediction of passive intestinal permeability. Existing computational models are surveyed and assessed in terms of descriptors, model type/complexity, speed of computation, predictive performance, and interpretability. Challenges to the successful computational prediction of intestinal permeability, i.e. data quantity, measurement imprecision, confounding factors such as solubility, metabolism, or active efflux, and the need for robust statistical methods, are also discussed.

[1]  Pravin Chaturvedi,et al.  Design principles for orally bioavailable drugs , 1996 .

[2]  K. Luthman,et al.  Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.

[3]  M Zschiesche,et al.  Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P‐glycoprotein , 2000, Clinical pharmacology and therapeutics.

[4]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  W. Rubas,et al.  Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption , 2004, Pharmaceutical Research.

[6]  S. Singer,et al.  The Fluid Mosaic Model of the Structure of Cell Membranes , 1972, Science.

[7]  U Norinder,et al.  Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  William G. Cochran,et al.  Experimental Designs, 2nd Edition , 1950 .

[9]  James W. McFarland,et al.  Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .

[10]  H. van de Waterbeemd,et al.  Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.

[11]  T I Oprea,et al.  Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.

[12]  P. Labute A widely applicable set of descriptors. , 2000, Journal of molecular graphics & modelling.

[13]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[14]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[15]  U Norinder,et al.  Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  Hamish Ryder,et al.  Prediction of Drug Permeability Based on Grid Calculations , 1999 .

[17]  S. Krämer,et al.  Absorption prediction from physicochemical parameters. , 1999, Pharmaceutical science & technology today.

[18]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[19]  B. Müller,et al.  Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.

[20]  Y. Martin,et al.  A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. , 1981, Journal of medicinal chemistry.

[21]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .

[22]  Ulf Norinder,et al.  Theoretical Calculation and Prediction of Caco-2 Cell Permeability Using MolSurf Parametrization and PLS Statistics , 1997, Pharmaceutical Research.

[23]  O. H. Chan,et al.  Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .

[24]  Peter J. Rousseeuw,et al.  Robust regression and outlier detection , 1987 .

[25]  G Camenisch,et al.  Cell permeability as a parameter for lead generation in the protein Tyrosine kinase inhibition field. , 2001, Bioorganic & medicinal chemistry letters.

[26]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[27]  P. Arnaud,et al.  HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. , 2001, Journal of pharmaceutical sciences.

[28]  Satinder Ahuja,et al.  Handbook of modern pharmaceutical analysis , 2001 .

[29]  D. Scherman,et al.  High lipophilicity decreases drug transport across intestinal epithelial cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[30]  S. Morgan,et al.  Outlier detection in multivariate analytical chemical data. , 1998, Analytical chemistry.

[31]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[32]  A. Leo,et al.  Partition coefficients and their uses , 1971 .

[33]  D. E. Clark Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[34]  G Folkers,et al.  Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.

[35]  Hans Lennernäs,et al.  Intestinal Permeability: Prediction from Theory , 2000 .

[36]  Akira Tsuji,et al.  Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.

[37]  Malcolm Rowland,et al.  Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption , 1996, Pharmaceutical Research.

[38]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[39]  Pickett,et al.  Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.

[40]  K. Luthman,et al.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.

[41]  Kararli Tt,et al.  Gastrointestinal absorption of drugs. , 1989 .

[42]  Shiyin Yee,et al.  In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.

[43]  G Houin,et al.  Gastrointestinal absorption of drugs: methods and studies , 1999, Fundamental & clinical pharmacology.

[44]  M. Yazdanian,et al.  Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.

[45]  David E. Clark,et al.  Enhancing the Hit-to-Lead Properties of Lead Optimization Libraries , 2000, J. Chem. Inf. Comput. Sci..

[46]  Yi Wang,et al.  Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans , 2000 .

[47]  J. Platts,et al.  Hydrogen bond structural group constants. , 2001, The Journal of organic chemistry.

[48]  A. Seelig,et al.  Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.

[49]  R T Borchardt,et al.  Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. , 2001, Current protocols in pharmacology.

[50]  A. Berglund,et al.  Structure-property model for membrane partitioning of oligopeptides. , 2000, Journal of medicinal chemistry.

[51]  J. S. Hunter,et al.  Statistics for experimenters : an introduction to design, data analysis, and model building , 1979 .

[52]  H Ahlbrecht,et al.  Minimal Molecular Determinants of Substrates for Recognition by the Intestinal Peptide Transporter* , 1998, The Journal of Biological Chemistry.

[53]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[54]  H Lennernäs,et al.  Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.

[55]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[56]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[58]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[59]  M H Tarbit,et al.  High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. , 1998, Current opinion in chemical biology.

[60]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[61]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[62]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[63]  E. Wright,et al.  Patterns of non-electrolyte permeability , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[64]  D. Manallack,et al.  Theoretical hydrogen bonding parameters for drug design. , 2001, Journal of molecular graphics & modelling.

[65]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[66]  Kristina Luthman,et al.  Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties , 1999, Pharmaceutical Research.

[67]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[68]  P Langguth,et al.  Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.

[69]  D. Massart,et al.  The Mahalanobis distance , 2000 .

[70]  R. Mannhold,et al.  Multivariate analysis of experimental and computational descriptors of molecular lipophilicity , 1998, Journal of computer-aided molecular design.

[71]  J. Diamond,et al.  Molecular forces governing non-electrolyte permeation through cell membranes , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[72]  A. Seelig,et al.  Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[73]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[74]  Roger Phan-Tan-Luu,et al.  Pharmaceutical Experimental Design , 1998 .

[75]  Han van de Waterbeemd,et al.  Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .

[76]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[77]  Kenneth M. Merz,et al.  Computation of the physio‐chemical properties and data mining of large molecular collections , 2002, J. Comput. Chem..

[78]  M. Kataoka,et al.  Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[79]  Y. Sugiyama,et al.  Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[80]  Y Zhang,et al.  Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.

[81]  U Norinder,et al.  Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. , 2001, Journal of pharmaceutical sciences.

[82]  John J. Baldwin,et al.  2 - Combinatorial Chemistry and High-Throughput Screening in Drug Discovery and Development , 2001 .

[83]  Albert J. Leo,et al.  Calculating log P(oct) with no missing fragments; The problem of estimating new interaction parameters , 2000 .

[84]  A. Barve,et al.  Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.

[85]  C. Hansch,et al.  Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.

[86]  P. Rousseeuw,et al.  Unmasking Multivariate Outliers and Leverage Points , 1990 .

[87]  D. Fleisher,et al.  Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.

[88]  Y Zhang,et al.  The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.

[89]  W J Dunn,et al.  Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.

[90]  A. Eckert,et al.  Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter. , 2001, Journal of pharmaceutical sciences.

[91]  Brahma N. Singh Effects of Food on Clinical Pharmacokinetics , 1999, Clinical pharmacokinetics.

[92]  R A Morrison,et al.  Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.

[93]  K Gubernator,et al.  Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.

[94]  K. Luthman,et al.  Virtual screening of intestinal drug permeability. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[95]  Sietsema Wk,et al.  The absolute oral bioavailability of selected drugs , 1989 .

[96]  Gianpaolo Bravi,et al.  Application of MS-WHIM Descriptors: 3. Prediction of Molecular Properties , 2000 .

[97]  D. Shen,et al.  Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.

[98]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[99]  B. Faller,et al.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.

[100]  J. H. Kou,et al.  Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[101]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[102]  K. Luthman,et al.  Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.

[103]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[104]  M. Yazdanian,et al.  Evaluation of an accelerated Caco-2 cell permeability model. , 2000, Journal of pharmaceutical sciences.

[105]  D. E. Clark,et al.  Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. , 2001, Combinatorial chemistry & high throughput screening.

[106]  Ulf Norinder,et al.  Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..

[107]  O. H. Chan,et al.  Use of immobilized artificial membrane chromatography for drug transport applications. , 1998, Journal of pharmaceutical sciences.

[108]  R. Welsch,et al.  The Hat Matrix in Regression and ANOVA , 1978 .

[109]  A. C. Rencher Methods of multivariate analysis , 1995 .

[110]  D Mackay,et al.  A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.

[111]  P. Artursson,et al.  A conditionally immortalized epithelial cell line for studies of intestinal drug transport. , 1999, The Journal of pharmacology and experimental therapeutics.

[112]  G Folkers,et al.  Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[113]  O. H. Chan,et al.  Physicochemical and drug-delivery considerations for oral drug bioavailability , 1996 .

[114]  A. Ghose,et al.  Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .

[115]  Vic Barnett,et al.  Outliers in Statistical Data , 1980 .

[116]  M. Kool,et al.  The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.

[117]  D. Thakker,et al.  Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium , 1997 .

[118]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.